Although PAI-1 has been considered as an inhibitor of cancer development, the proangiogenic and promigratory effects of PAI-1 promote tumor growth at physiological concentration by stimulating plasmin-mediated proteolysis 40. This evidence concerns the gene PLG and neoplasm.